Medically graded reduced capacity to work (RCW) following significant injury as explained by patient related outcome measures (PROMs) – a prospective trauma center evaluation

IntroductionPrehabilitation in colorectal surgery is evolving and may minimise postoperative morbidity and mortality. With many different healthcare professionals contributing to the prehabilitation literature, there is significant variation in reported primary endpoints that restricts comparison. In addition, there has been limited work on patient-related outcome measures suggesting that patients with colorectal cancer needs and issues are being overlooked. The Defining Standards in Colorectal Optimisation Study aims to achieve international consensus from all stakeholders on key standards to provide a framework for reporting future prehabilitation research.Methods and analysisA systematic review will identify key standards reported in trials of prehabilitation in colorectal surgery. Standards that are important to patients will be identified by a patient and public involvement (PPI) event. The longlist of standards generated from the systematic review and PPI event will be used to develop a three-round online Delphi process. This will engage all stakeholders (healthcare professionals and patients) both nationally and internationally. The results of the Delphi will be followed by a face-to-face interactive consensus meeting that will define the final standards for prehabilitation for elective colorectal surgery.Ethics and disseminationThe University of Glasgow College of Medical, Veterinary and Life Sciences Ethics Committee has approved this protocol, which is registered as a study (200190120) with the Core Outcome Measures in Effectiveness Trials Initiative. Publication of the standards developed by all stakeholders will increase the potential for comparative research that advances understanding of the clinical application of prehabilitation.PROSPERO registration numberCRD42019120381.

Download Full-text

Patient Related Outcome Measures (PROMs) in Morton’s Neuroma: Conservative vs. Surgical Management at One-Year Follow-Up

Foot & Ankle Orthopaedics ◽

10.1177/2473011419s00021 ◽

2019 ◽

Vol 4 (4) ◽

pp. 2473011419S0002

Author(s):

Alastair Faulkner ◽

Alistair Mayne ◽

Fraser Harrold

Keyword(s):

Outcome Measures ◽

Surgical Management ◽

Conservative Management ◽

Morton’S Neuroma ◽

Significant Difference ◽

Morton's Neuroma ◽

One Year ◽

Patient Related Outcome ◽

Eq Vas

Category: Midfoot/Forefoot Introduction/Purpose: Morton’s neuroma is a common condition affecting the foot and is associated with chronic pain and disability. Conservative management including a combination of orthotic input; injection or physiotherapy, and surgical excision are current treatment options. There is a paucity of literature regarding patient related outcome measures (PROMs) data in patients managed conservatively. We sought to compare conservative with surgical management of Morton’s neuroma using PROMs data in patients with follow-up to one year. Methods: Prospective data collection commenced from April 2016. Patients included had to have a confirmed Morton’s neuroma on ultrasound scan. Patient demographics including age, sex and BMI were collected. The primary outcome measures were the Manchester Foot Score for pain (MOX-FQ), EQ time trade off (TTO) and EQ visual analogue scale (VAS) taken pre-operatively; at 26-weeks and at 52-weeks post-operatively. Results: 194 patients were included overall: 79 patients were conservatively managed and 115 surgically managed. 19 patients were converted from conservative to surgical management. MOX-FQ pain scores: pre-op conservative 52.15, surgical 61.56 (p=0.009), 6-months conservative 25.1, surgical 25.39 (p=0.810), 12 months conservative 18.54, surgical 20.52 (p=0.482) EQ-TTO scores: pre-op conservative 0.47, surgical 0.51 (p=0.814), 6-months conservative 0.41, surgical 0.49 (p=0.261), 12 months conservative 0.26, surgical 0.37 (p=0.047) EQ-VAS scores: pre-op conservative 63.84, surgical 71.03 (p=0.172), 6-months conservative 46.10, surgical 52.51 (p=0.337), 12 months conservative 30.77, surgical 37.58 (p=0.227) Satisfaction at 12 months: conservative 17 (21.5%), surgical 32 (27.8%) p=0.327 Conclusion: This is one of the first studies investigating long-term PROMs specifically in conservative management for Morton’s neuroma patients. There was no significant difference in pain score and EQ-VAS between all conservative treatments and surgical management at 12 months There was no significant difference in satisfaction at 12 months between conservative and surgical groups.

Download Full-text

Effect of combination treatment on patient-related outcome measures in benign prostatic hyperplasia: clinical utility of dutasteride and tamsulosin

Patient Related Outcome Measures ◽

10.2147/prom.s13062 ◽

2011 ◽

pp. 71 ◽

Cited By ~ 4

Author(s):

Robert Djavan ◽

Syed Saeid Dianat ◽

Kazzazi

Keyword(s):

Benign Prostatic Hyperplasia ◽

Outcome Measures ◽

Combination Treatment ◽

Clinical Utility ◽

Prostatic Hyperplasia ◽

Patient Related Outcome

Download Full-text

Long-term patient-related outcome measures of septoplasty: a systematic review

European Archives of Oto-Rhino-Laryngology ◽

10.1007/s00405-018-4874-y ◽

2018 ◽

Vol 275 (5) ◽

pp. 1039-1048 ◽

Cited By ~ 3

Author(s):

Chi Lap Nicholas Tsang ◽

Theresa Nguyen ◽

Torunn Sivesind ◽

Anders Cervin

Keyword(s):

Systematic Review ◽

Outcome Measures ◽

Patient Related Outcome

Download Full-text

Patient-Related Outcome Measures (PROMs) With Nonoperative and Operative Management of Morton’s Neuroma

Foot & Ankle International ◽

10.1177/1071100720961069 ◽

2020 ◽

pp. 107110072096106

Author(s):

Alastair Faulkner ◽

Alistair Mayne ◽

Peter Davies ◽

David Ridley ◽

Fraser Harrold

Keyword(s):

Outcome Measures ◽

Operative Management ◽

Symptom Improvement ◽

Morton’S Neuroma ◽

Level Of Evidence ◽

Morton's Neuroma ◽

Patient Related Outcome ◽

New Diagnosis ◽

Eq Vas

Background: Morton’s neuroma is associated with chronic pain and disability. There is a paucity of literature regarding patient-related outcome measures (PROMs) in patients managed nonoperatively. We sought to investigate nonoperative and operative management of Morton’s neuroma using PROMs in patients with follow-up to 1 year. Methods: We conducted a prospective observational study and collected data on all patients with a new diagnosis of Morton’s neuroma treated from February 2016 until April 2018. Primary outcome measures were the Manchester-Oxford Foot Questionnaire (MOXFQ) for pain, EuroQoL (EQ) time trade-off (TTO), and EQ visual analog scale (VAS) taken preoperatively and at 52 weeks postoperatively. Forty-four patients were treated nonoperatively and 94 patients were treated operatively. Results: Pretreatment and 52-week scores were 55.7 and 43.10 (nonoperative) and 63.7 and 40.1 (operative) for MOXFQ (pain), 0.72 and 0.82 (nonoperative) and 0.68 and 0.82 (operative) for EQ-TTO, and 71.5 and 76.2 (nonoperative) and 73.1 and 68.7 (operative) for EQ-VAS. There was a statistically significant improvement in MOXFQ (pain) in nonoperative ( P = .02) and operative groups ( P < .001). There was a statistically significant improvement in EQ-TTO in the operative group only ( P = .01). Conclusion: This is the largest study investigating outcomes to 12 months of both nonoperative and operatively managed patients with Morton’s neuroma. Both nonoperative and operative management lead to symptom improvement at 12 months. Level of Evidence: Level III, comparative study.

Download Full-text

Does Care at a Trauma Center Affect Geriatric Hip Fracture Patients?

Geriatric Orthopaedic Surgery & Rehabilitation ◽

10.1177/2151459320911865 ◽

2020 ◽

Vol 11 ◽

pp. 215145932091186

Author(s):

Jordan B. Pasternack ◽

Matthew L. Ciminero ◽

Michael Silver ◽

Joseph Chang ◽

Piyush Gupta ◽

...

Keyword(s):

Hip Fracture ◽

Outcome Measures ◽

Hip Fractures ◽

Complication Rate ◽

Trauma Center ◽

Secondary Outcome ◽

Transfusion Rate ◽

Geriatric Hip Fracture ◽

Level 1 ◽

Level 1 Trauma Center

Introduction: With respect to care setting, there are mixed results in the literature with respect to the role of trauma centers in management of isolated geriatric hip fractures. During a transition from a Level 3 to a Level 1 trauma center, significant protocol changes were implemented that sought to standardize and improve the care of hip fracture patients. The objective of this study was to determine the effects of this transition on the management, efficiency, morbidity, mortality, and discharge of geriatric hip fracture patients. Methods: A retrospective chart review of geriatric hip fractures treated operatively was conducted. Two cohorts were compared: hip fractures in the year prior to (2015) and year following (2017) Level 1 Trauma designation. Primary outcome measures were length of stay (LOS), transfusion rate, complication rate, and mortality rate. Secondary outcome measures were time from emergency department (ED) arrival to medical optimization, time from medical optimization to surgery, time from ED arrival to surgery, and discharge destination. Results: There were no differences in LOS, transfusion rate, or complication rate between the two cohorts. There was a nonsignificant trend toward lower in-hospital mortality after the transition (2.24% vs 0.83%). There were no differences in time from ED arrival to medical optimization, time from medical optimization to surgery, time from ED arrival to surgery, and percentage of patients discharged home between the cohorts. Discussion: Management of operative geriatric hip fractures at our institution has remained consistent following transition to a Level 1 trauma center. There was a trend toward lower mortality after transition, but this difference was not statistically significant. We attribute the variety of findings in the literature with respect to trauma center management of hip fractures to individualized institutional trauma protocols as well as the diverse patient populations these centers serve.

Download Full-text

A comparison of telephone and paper self-completed questionnaires of main patient-related outcome measures in patients with ankylosing spondylitis and psoriatic arthritis

Rheumatology International ◽

10.1007/s00296-013-2800-6 ◽

2013 ◽

Vol 33 (11) ◽

pp. 2731-2736 ◽

Cited By ~ 6

Author(s):

Rafael Ariza-Ariza ◽

Blanca Hernández-Cruz ◽

Victoria Navarro-Compán ◽

Christian Leyva Pardo ◽

Xavier Juanola ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Ankylosing Spondylitis ◽

Outcome Measures ◽

Patient Related Outcome

Download Full-text

Domains and instruments

10.1093/med/9780198737582.003.0023 ◽

2018 ◽

Author(s):

Alberto Cauli

Keyword(s):

Psoriatic Arthritis ◽

Outcome Measures ◽

Outcome Measurement ◽

Real Life ◽

Therapeutic Trials ◽

Measurement Tools ◽

Definition Of ◽

Patient Related Outcome ◽

Composite Scores ◽

Intensive Work

In order to define and validate standardized outcome measurement tools both for therapeutic trials and for real life clinics, the need to precisely identify the relevant domains of psoriasis and psoriatic arthritis has led to the ‘rassemblement’ of experts and patients in the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The output of intensive work, performed according to the Outcome Measures in Rheumatology (OMERACT) scientific method, has been the definition of the key domains and instruments relevant in PsA evaluation. This chapter summarizes the present approach in PsA assessment, focusing on the ‘pathophysiological manifestations’, as well as current ideas regarding future revisions. Patient-related outcome measures and composite scores will be detailed in other chapters.

Download Full-text